FAIRLESS HILLS, Pa. (AP) — Johnson Johnson is ending sales of its iconic talc-based Johnson’s Baby Powder in the U.S. and Canada, where demand has dwindled amid thousands of lawsuits claiming it has caused cancer.
The world’s biggest maker of health care products said Tuesday the talc-based powder will still be sold outside the U.S. and Canada.
“Demand for talc-based Johnson’s Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising,” the company said.
The company insists, and the overwhelming majority of medical research on talc indicates, that the talc baby powder is safe and doesn’t cause cancer.
The New Brunswick, New Jersey, company said the baby powder decision came as it moves to discontinue about 100 consumer health products.
